TrialJournal of gastroenterology2026

Usefulness of an S-1 dosage formula for predicting adverse events in adjuvant chemotherapy for curatively resected pancreatic cancer: an exploratory analysis of the randomized clinical trial (JASPAC-01).

Kazunaga Ishigaki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.